Comparison of Pandemic Excess Mortality in 2020-2021 Across Different Empirical Calculations
Overview
Affiliations
Different modeling approaches can be used to calculate excess deaths for the COVID-19 pandemic period. We compared 6 calculations of excess deaths (4 previously published [3 without age-adjustment] and two new ones that we performed with and without age-adjustment) for 2020-2021. With each approach, we calculated excess deaths metrics and the ratio R of excess deaths over recorded COVID-19 deaths. The main analysis focused on 33 high-income countries with weekly deaths in the Human Mortality Database (HMD at mortality.org) and reliable death registration. Secondary analyses compared calculations for other countries, whenever available. Across the 33 high-income countries, excess deaths were 2.0-2.8 million without age-adjustment, and 1.6-2.1 million with age-adjustment with large differences across countries. In our analyses after age-adjustment, 8 of 33 countries had no overall excess deaths; there was a death deficit in children; and 0.478 million (29.7%) of the excess deaths were in people <65 years old. In countries like France, Germany, Italy, and Spain excess death estimates differed 2 to 4-fold between highest and lowest figures. The R values' range exceeded 0.3 in all 33 countries. In 16 of 33 countries, the range of R exceeded 1. In 25 of 33 countries some calculations suggest R > 1 (excess deaths exceeding COVID-19 deaths) while others suggest R < 1 (excess deaths smaller than COVID-19 deaths). Inferred data from 4 evaluations for 42 countries and from 3 evaluations for another 98 countries are very tenuous. Estimates of excess deaths are analysis-dependent and age-adjustment is important to consider. Excess deaths may be lower than previously calculated.
Does mask usage correlate with excess mortality? Findings from 24 European countries.
Tausk D, Spira B BMC Public Health. 2025; 25(1):913.
PMID: 40069661 PMC: 11900040. DOI: 10.1186/s12889-025-22172-x.
Moulaire P, Hejblum G, Lapidus N BMJ Public Health. 2025; 3(1):e001836.
PMID: 40051536 PMC: 11883889. DOI: 10.1136/bmjph-2024-001836.
Cilovic-Lagarija S, Rantzau J, Skocibusic S, Musa S, Spreco A, Isakovic A Influenza Other Respir Viruses. 2025; 19(3):e70086.
PMID: 40010310 PMC: 11864808. DOI: 10.1111/irv.70086.
Ioannidis J Eur J Epidemiol. 2024; 39(11):1211-1219.
PMID: 39565536 DOI: 10.1007/s10654-024-01169-7.
Pizzato M, Gerli A, La Vecchia C, Alicandro G Lancet Reg Health Eur. 2024; 44:100996.
PMID: 39410937 PMC: 11473197. DOI: 10.1016/j.lanepe.2024.100996.